See analyst estimates and all valuation multiples for BioTech
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $693B | 12.4x | 29.4x | |
| $459B | 5.0x | 13.7x | |
| $436B | 7.4x | 16.1x | |
| $284B | 3.7x | 9.4x | |
| $271B | 4.7x | 13.6x | |
| $268B | 4.9x | 11.9x | |
| $237B | 3.7x | 8.3x | |
| $215B | 4.9x | 19.7x | |
| $203B | 5.8x | 10.9x | |
| $188B | 3.0x | 7.6x | |
| $162B | 6.6x | 21.1x | |
| $160B | 5.6x | 11.2x | |
| $133B | 2.8x | 9.3x | |
| $97.3B | 2.3x | 6.7x | |
| $95.4B | 8.2x | 24.5x | |
| $75.4B | 4.9x | 14.5x | |
| $65.3B | 8.0x | 15.9x | |
| $37.6B | 5.5x | 19.2x | |
| $23.2B | 2.4x | 7.1x | |
| $22.5B | 2.3x | 6.6x | |
| $22.3B | 6.6x | 22.4x | |
| $22.3B | 11.4x | -89.2x | |
| $22.1B | 7.5x | 8.1x | |
| $19.1B | 6.2x | 17.2x | |
| $18.7B | 40.3x | 136.7x | |
| $18.2B | 16.1x | 50.1x | |
| $17.5B | 11.3x | 32.8x | |
| $17.5B | 42.0x | -1647.3x | |
| $17.5B | 4.0x | 15.8x | |
| $17.3B | 4.0x | 15.1x | |
| $16.4B | 114.3x | 206.6x | |
| $16.2B | 3.4x | 14.2x | |
| $16.2B | 5.7x | 16.1x | |
| $14.1B | 3.1x | 14.3x | |
| $13.5B | 4.2x | 16.6x | |
| $12.8B | 2.8x | 14.5x | |
| $12.1B | n/a | n/a | |
| $11.0B | 3.5x | 8.8x | |
| $10.7B | 1.7x | 5.5x | |
| $10.6B | 2.7x | 10.9x | |
| $9.5B | 7.8x | 12.0x | |
| $9.2B | 3.8x | 42.6x | |
| $9.1B | 14.2x | -28.0x | |
| $8.3B | n/a | n/a | |
| $7.6B | 4.1x | 16.7x | |
| $7.4B | 7.8x | 37.8x | |
| $7.0B | 8.7x | n/a | |
| $7.0B | 4.5x | 22.9x | |
| $6.8B | 1.8x | 8.9x | |
| $6.6B | 5.1x | 20.6x | |
| $6.6B | 1.6x | 8.4x | |
| $6.3B | 2.7x | 10.0x | |
| $5.8B | 6.4x | -43.8x | |
| $5.8B | 17.9x | -55.6x | |
| $5.8B | 2.2x | 12.4x | |
| $5.1B | 1017.5x | -5.5x | |
| $4.5B | 1.3x | 7.2x | |
| $3.6B | 6.0x | 17.7x | |
| $3.2B | 2.5x | 11.4x | |
| $2.7B | 2.9x | 16.9x | |
| $2.6B | 33.3x | n/a | |
| $2.5B | 3.7x | 135.1x | |
| $2.5B | 3.2x | 17.4x | |
| $2.3B | 5.8x | 17.3x | |
| $2.2B | 3.9x | 43.2x | |
| $2.1B | 600.6x | -143.0x | |
| $2.1B | 18.3x | 87.7x | |
| $2.0B | 3.0x | 11.8x | |
| $1.9B | n/a | n/a | |
| $1.9B | 2.5x | 9.6x | |
| $1.6B | 24.0x | -2.9x | |
| $1.3B | 30.5x | -2.8x | |
| $1.3B | 3.1x | 15.2x | |
| $1.3B | 2.0x | -71.4x | |
| $1.2B | 1.7x | 12.1x | |
| $1.0B | 1.2x | 4.1x | |
| $909M | 3.7x | 9.5x | |
| $859M | 7.3x | -12.6x | |
| $829M | 7.4x | -7.5x | |
| $727M | n/a | n/a | |
| $724M | 60.2x | -6.1x | |
| $690M | n/a | n/a | |
| $559M | 2.7x | -41.2x | |
| $559M | 2.0x | 8.7x | |
| $494M | 1.3x | 11.4x | |
| $333M | n/a | -1.4x | |
| $320M | 370112.7x | -13.0x | |
| $272M | 1.1x | 7.5x | |
| $248M | 5.2x | 19.1x | |
| $179M | n/a | -11.7x | |
| $167M | 3.5x | -2.3x | |
| $155M | 1.2x | -9.0x | |
| $141M | 5.0x | -4.9x | |
| $126M | 1.9x | n/a | |
| $125M | n/a | -1.3x | |
| $54.6M | n/a | n/a | |
| $49.5M | 426.8x | n/a | |
| $21.7M | 0.8x | -46.1x | |
| $3.8M | n/a | n/a | |
| -$223M | n/a | n/a |